CClinicalTrials.gg
CompletedNCT02820480RehabCaresUpdated Oct 14, 2019

Design of an Affordable Gym for Post Stroke Rehabilitation

An observational study in Stroke, Cerebral Palsy and Healthy, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-14.

Sponsored by University of Pennsylvania · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

Rehab in a Crate is a therapy gym designed to be affordable, compact and easily transportable. The purpose of this particular study is to gain feedback on the initial design of the Rehab in a Crate system. This will be accomplished by using qualitative ethnographic research methods (i.e. human centered design) in the form of surveys that have been carefully designed by members of the research team. The eligibility criteria of this survey research reflects the intended user base of an eventual finished product, which is survivors of stroke and cerebral palsy across the globe. And while healthcare professionals are not the user base per se, their expertise and feedback should be instrumental in the design of future iterations of the Rehab in a Crate. Ease of use, utility, design, and various features, both existing and intended, will all be surveyed items.

Read the detailed description

The investigators aim to survey stroke survivors and healthcare professionals on the design, ease of use, utility, and various features of, both existing and those yet-to-be-developed. This feedback will help to fine tune further development of this therapy gym, Rehab in a Crate, and move forward in the iteration process.

Note: The device is not being used at this moment for diagnostic or evaluation.

02

Conditions studied

  • Stroke
  • Cerebral Palsy
  • Healthy

Keywords

  • stroke
  • rehabilitation
  • robotics
  • cerebral palsy
  • therapy
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 20 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Therapists and patients with neuro-rehab. Patients with neural injury

Inclusion criteria

  • Stroke survivors who are more than 3 months post stroke and persons with cerebral palsy adults - have hemiplegia or diplegia
  • Health professionals who have considerable experience in stroke rehabilitation.

Exclusion criteria

Exclusion Criteria:

  • Anyone who is not 18 years of age.
  • More than mild spasticity in the upper of lower extremities.
  • A cognitive score on the Montreal Cognitive Assessment that indicates that the participant is cognitively impaired.
  • Motor impairment that precludes interaction with the Rehab in a Crate (e.g. unable to grip a handle).
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients/health professionals

    Stroke AND cerebral palsy PATIENTS: greater than 18 years of age, who are more than 3 months post stroke, as well as health professionals who have considerable experience in stroke rehabilitation will be asked to evaluate the design of the Rehab in a Crate system. The aim is to survey stroke survivors and healthcare professionals on the design, ease of use, utility, and various features of, both existing and those yet-to-be-developed.

    Device: Rehab in a Crate System

Interventions

  • DeviceRehab in a Crate System

    The therapy gym is Rehab in a Crate with 4 stations for upper and lower limb assessment/therapy. Each station will allow adaptive game-based therapy. Note: The device is not being used at this moment for diagnostic or evaluation. Users will be asked to explore the device, try the systems, and provide feedback about use.

06

What researchers measure

Primary outcomes

  1. Acceptability of Rehab system

    The ability to accept the product for use in rehab; An ethnographic survey/questionnaire will be administered to the subjects.

    Time frame: 1 session, about 1.5 hours in length

Secondary outcomes

  1. Usability of Rehab System

    The ability to use the product for therapy as intended

    Time frame: 1 session, about 1.5 hours in length

07

Study locations

1 site
  • Penn Medicine Rittenhouse
    Philadelphia, Pennsylvania 19146, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02820480
Lead sponsor
University of Pennsylvania
Responsible party
Sponsor
First posted
Jul 1, 2016
Start date
Nov 2015
Primary completion
Aug 2019
Completion
Aug 2019
Last update
Oct 14, 2019

Study contacts

Michelle J Johnson, PhD
principal investigator · Penn Medicine Rittenhouse

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion